baber/WOPTO huggingface dataset:
Patent NZ-253262-A (NZ)
Title: Pharmaceutical composition; nsaid agent and a bile acid, salt or ester as the carrier
Inventor: BARNWELL STEPHEN GEORGE
IPC: A61K9/52
Filed: 1993-06-11
Abstract: PCT No. PCT/GB93/01247 Sec. 371 Date Feb. 2, 1995 Sec. 102(e) Date Feb. 2, 1995 PCT Filed Jun. 11, 1993 PCT Pub. No. WO93/25192 PCT Pub. Date Dec. 23, 1993Non-steroidal anti-inflammatory drugs, such as indomethacin, and other pharmaceutically active compounds, are formulated with bile acids or their salts and conjugates. Bile acids previously proposed for use in such formulations have placed an unacceptable toxic load on the liver and/or cells of the gastrointestinal tract, causing abnormal liver function or cell erosion. In this invention, the bile acid is a low detergent bile acid, such as ursodeoxycholate. Stabilization of the bile acid pool results in enhanced and predictable enterohepatic recycling of NSAIDs (and other drugs) and a reduced risk of toxicity.
Patent NZ-273045-A (NZ)
Title: Voice activity detector
Inventor: BARRETT PAUL ALEXANDER
IPC: G10L25/78
Filed: 1994-09-14
Abstract: Speech is distinguished from noise by a spectral comparison of an input signal with a stored noise estimate. Updating of the noise estimate stored in a buffer is permitted during periods when speech is absent under control of an auxiliary detector. In order to improve operation in the presence of signals with strong harmonic components, e.g., signaling tones, an LPC prediction gain is computed from the input (x(i)) and a residual (y(i)) obtained from the input following filtering by a filter having a response complementary to the frequency spectrum of the input, and if the gain exceeds a threshold, buffer updating is suppressed.
Patent NZ-302466-A (NZ)
Title: Receiver switched off after word repeat to save battery power
Inventor: KOLEV IAVOR
IPC: H04W52/02
Filed: 1996-02-14
Abstract: In a method and an apparatus for reducing the power consumption of a battery operated transceiver in standby mode, particularly a mobile telephone station, in which the receiver of the transceiver is adapted to receive successive word blocks on a forward control channel, each word block consisting of a predetermined number of bits forming a dotting sequence, a word synchronization sequence and a predetermined number of word repeats, a switching device is adapted to switch off the receiver after a word repeat in a word block has been validly received, and to switch on the receiver to receive a word repeat in the next successive word block.
Patent NZ-323543-A (NZ)
Title: Substituted 4-(1h-benzimidazol-2-yl-amino)piperidine derivatives useful for the treatment of allergic diseases
Inventor: KANE JOHN MICHAEL
IPC: A61P11/06
Filed: 1996-11-07
Abstract: The present invention relates to novel substituted piperidine derivatives of formula (1), stereoisomers thereof, and pharmaceutically acceptable salts thereof which are useful as histamine receptor antagonists and tachykinin receptor antagonist. Such antagonists are useful in the treatment of allergic rhinitis, including seasonal rhinitis and sinusitis; inflammatory bowel diseases, including Crohn's disease and ulcerative colitis; asthma; bronchitis; and emesis.
Patent NZ-331566-A (NZ)
Title: The use of inhibitors of the sodium-hydrogen exchanger such as a benzoylguanidine in the production of a pharmaceutical for the treatment of diseases caused by protozoa
Inventor: LANG HANS JOCHEN
IPC: A61P33/02
Filed: 1998-08-26
Abstract: A Na+/H+ exchanger inhibitor is used in the manufacture of a medicament for the treatment or prophylaxis of disease caused by protozoa such as topical malaria.  The Na+/H+ exchanger inhibitor is a substituted benzoyl guanidine, isoquinoline, benzoxazole, benzothiophene, indole, benzimidazole, benzothiazine, benzofuran, indenoyl guanidine, substituted diacylguanidine, isoquinoline acylguanidine, benzothiazine acylguanidine, fluoroalkyl substituted phenylalkyl carboxylic acid guanidide, furan guanidine, thiophene guanidine, pyrrole guanidine, bicyclic heteroaroyl guanidine, substituted phenylalkenyl carboxylic acid guanidide, benzyloxycarbonyl guanidine, fluorophenyl substituted alkenylcarboxylic acid guanidide, cinnamic acid guanidide, sulphonimidamide substituted benzoyl guanidine, biphenyldicarboxylic acid diguanidide, benzenedicarboxylic acid diguanidide, thiophenylalkenylcarboxylic acid guanidide, 1- or 2-naphthoyl guanidine, indanylidineacetyl guanidine, 6-membered N containing heterocyclic guanidine, indoloyl guanidine, guanidine, benzofuran guanidine, benzothiophene guanidine or indolyl guanidine derivative such as: 3-dimethylamino-5-trifluoromethylbenzoylguanidine, 3-phenyl-5-trifluoromethylbenzoylguanidine, 3-isopropyl-4-fluoro-5-trifluoromethylbenzoylguanidine, 3-chloro-5-(1-pyrrolyl)benzoylguanidine, 3-chloro-5-trifluoromethylbenzoylguanidine, 3-dimethylamino-5-(1-pyrrolyl)benzoylguanidine, 3-dimethylamino-4-tert-butylbenzoylguanidine, 4-(3-chloroanilino)-3-methylsulphonylbenzoylguanidine, 4-(4-aminoethylphenoxy)-3-methylsulphonylbenzoylguanidine, 4-(4-aminoethylsulphonylmethylphenoxy)-3-trifluoromethylbenzoylguanidine, 4-(4-aminoethylthiophenoxy)-3-trifluoromethylbenzoylguanidine, 3,5-di-tert-butylbenzoylguanidine, 3,5-di-tert-butyl-4-hydroxybenzoylguanidine, 5-chloro-2-indoloylguanidine, 3,5-dichloro-2-indoloylguanidine, 5-chloro-3-phenylthio-2-indoloylguanidine, 5-chloro-3-phenylsulphonyl-2-indoloylguanidine, 5-methoxy-3-isopropyl-2-indoloylguanidine, 4-benzyloxy-2-indoloylguanidine, 5-chloro-1-(4-picolyl)-2-indoloylguanidine, 2-(4-hydroxyphenyl)-4-benzimidazolylguanidine or N-{3-[3-(3-guanidino-2-methyl-3-oxopropenyl)phenyl]2-methylacryloyl}guanidine.
Patent NZ-332775-A (NZ)
Title: Polyol succinates and their pharmaceutical formulation
Inventor: BJORKLING FREDRIK
IPC: C07C69/40
Filed: 1997-06-04
Abstract: Compounds of formula (I) in which Y and Q are independently selected from hydrogen or alkyl groups, optionally substituted by 1-4 hydroxy or 1-4 R3O2CCH2CH2CO2- groups, where R3 is hydrogen or an alkyl group, and R1 and R2 are alkyl, and solvates and prodrugs thereof and the salts thereof in which R3 is a hydrogen atom. These compounds can be used in the treatment of diseases caused by or resulting in metabolic dysfunction and/or energy deprivation, such as diabetes, acute starvation, endotoxemia, sepsis, systemic inflammatory response syndrome and multiple organ dysfunction syndrome.
Patent NZ-336491-A (NZ)
Title: Treating dewatered organic sludge with an alkaline material and controlling the amount of alkaline material present through measuring the water content of the sludge
Inventor: MILLARD ROBIN
IPC: C02F11/147
Filed: 1997-12-24
Abstract: Provided is a process for treating organic sludge, such as sewage, in which dewatered sludge cake and an alkaline admixture are mixed and then dried under pasteurization conditions utilizing heat from the exothermic reaction that results, in which drying is effected by extraction of moisture evaporated from the mixture by the exothermic reaction, and in which the dewatered sludge cake is measured for water content and the measure used to control the alkaline admixture. Preferably drying is effected in a cycling operation until a predetermined moisture content is detected and then the dried material is discharged.
Patent NZ-336572-A (NZ)
Title: Aqueous dispersion containing a cellulose-reactive sizing agent and an anionic hydrophobically modified cellulose derivative for papermaking stocks with high cationic and lipophillic compounds
Inventor: FROLICH STEN
IPC: D21H/
Filed: 1998-02-03
Abstract: The use of an aqueous sizing dispersion containing a cellulose-reactive sizing agent and a hydrophobically modified dispersing agent for sizing cellulosic fibres by addition of the sizing dispersion to a stock containing cellulosic fibres, and optional fillers, and dewatering the stock on a wire to obtain a web containing cellulosic fibres, wherein the stock has a cationic demand of at least 50 meq/litre stock filtrate. The dispersion further relates to an aqueous dispersion containing a cellulose-reactive sizing agent and an anionic hydrophobically modified cellulose-derivative, its preparation and use in the production of paper. The dispersion also relates to a substantially water-free composition containing a cellulose-reactive sizing agent and an anionic hydrophobically modified cellulose-derivative, its preparation and use in the preparation of an aqueous dispersion of cellulose-reactive sizing agent.
Patent NZ-503404-A (NZ)
Title: The presence of unique DNA and RNA molecules in prostate tumour cells and their use in diagnostic detection methods
Inventor: LAUS REINER
IPC: C07K19/00
Filed: 1998-08-18
Abstract: Sequences for polynucleotides specific to human prostate tumor cells, the polypeptides encoded by them and corresponding antibodies are provided.  Expression of prostate tumor antigens in an individual and tumor cells in a tissue sample may be detected using the polypeptide sequences.
Patent NZ-505116-A (NZ)
Title: Collapsible container, typically with inner lining surface, and with inner surfaces of opposing sidewall pair having inwardly projecting zones at ends
Inventor: KARPISEK LADISLAV STEPHAN
IPC: B65D19/12
Filed: 1998-12-07
Abstract: A collapsible container with four side panels (15,16,17,18) all permanently connected to a base by links allowing the panels (15,16,17,18) to be moved between an upstanding condition on the base where they are retained by engagement of bottom panel flanges with channels (13,14) on the base and can be coupled by coupling means releasably secured by securing means thereby to form an enclosure and allowing the container to be collapsed by folding down the panels (15,16,17,18) into an overlying relationship.
Patent NZ-507256-A (NZ)
Title: Method for conveying on high-density bed powder materials and device with potential fluidisation for implementing same
Inventor: GASQUET GERARD
IPC: B65G53/52
Filed: 1999-05-06
Abstract: A method for conveying a powder material (12) on high- density bed by potential fluidisation, using a device comprising at least an air pipe system (3) comprising a lower pipe (5) for circulating a fluidizing gas (G), an upper pipe (7) for circulating the powder material (12), the two pipes being separated by a porous wall (6), at least a pipe (8) supplying gas (G) and an adjusting column (4.1, 4.2) whereof the filling height (h) adjusts the potential fluidisation pressure. The method is characterised in that it consists in generating in the upper pipe (7) of the air pipe system (3) a gas bubble (B1, B2) under pressure. The bubble is durably located in said air pipe system (3) upper pipe (7) upper portion (14).
Patent NZ-507785-A (NZ)
Title: High performance composite membrane
Inventor: RICE WILLIAM C
IPC: B01D69/10
Filed: 1999-05-18
Abstract: A process for continuously coating a porous substrate to prepare a composite filtration membrane comprises providing a first liquid component and a first applicator means for applying the first liquid component onto the substrate. The first applicator means comprises a slot die head or a direct gravure applicator.  A quantitative amount of the first component is applied, onto the substrate to coat the substrate and form a liquid layer, by relatively moving the substrate and the first applicator with respect to each other at a speed of between 20 and 200 feet per minute. A second liquid component is provided and a second applicator means in tandem with the first applicator means for applying the second liquid component The second applicator means comprises a slot die head. A quantitative amount of the second liquid component is applied onto the liquid layer to contact the second liquid component with the liquid layer by relatively moving the substrate coated with the liquid layer and the second applicator with respect to each other. The first and second liquid component is allowed to interfacially polymerize to form a composite layer of a thickness of between about 25 Å and 1 micron. The composite layer is dried to form a composite membrane. Also described is a composite filtration membrane having reverse osmosis properties with the membrane formed from the process described above comprising a composite permeable barrier coating deposited on a microporous substrate. The barrier coating comprises a first layer having a reactant comprising metaphenylenediamine and a second layer having a reactant comprising trimesyol chloride. A composite filtration membrane having nanofiltration properties where the membrane is formed by the above process is also described. The membrane comprises a microporous substrate and a composite permeable barrier where in the barrier coating consists a first layer having a reactant comprising poly(etheyleneimine) and a second layer having a reactant comprising cyanuric chloride An ultra filtration membrane is formed by continuously coating a porous substrate. The process consists of providing a liquid component and an applicator means for applying the liquid component onto the substrate. The component is applied onto the substrate to coat the substrate and form a liquid layer by relatively moving the substrate and the applicator with respect to each other at a rate of between 20 and 200 feet per minute. The layer is then dried to from an ultrafiltration membrane.
Patent NZ-510057-A (NZ)
Title: Gels and multilayer surface structures from boronic acid containing polymers
Inventor: HUBBELL JEFFREY A
IPC: C08F230/06
Filed: 1999-08-27
Abstract: Cells, tissue or a device for implanting into a patient have  a  coating applied to a surface in vitro or  ex  vivo. The  coating  minimizes or prevents cell or tissue  adhesion to  the surface.  The coating comprises a polymer containing more  than one boronic acid group crosslinked with more than one  hydroxyl  or  carboxyl acid  functional  group  on  the surface.
Patent NZ-515825-A (NZ)
Title: Security turnkey and lock system
Inventor: KLEINHAENI ARNO
IPC: E05B27/10
Filed: 2001-04-02
Abstract: The security reversible key with an assigned cylinder Z has a blocking groove BN with a coded blocking depth (B1, B2, B3), which runs parallel to the axis of the key (x) from the tip of the key to at least the first position (P1) of a row of tumbler pins (A2) on the key. In the assigned cylinder at least at the rearmost coding position (P1) a pair of tumbler pins corresponding to the blocking groove BN with a blocking tumbler pin BZ and an extended blocking counter pin BG are foreseen, whereby the blocking counter pin BG impinges on the cylinder housing (10), if the blocking groove is insufficiently deep and with this the complete insertion of a key with an insufficiently deep blocking groove is blocked by the pair of blocking tumbler pins. Simultaneously the blocking tumbler pin BZ with the counter pin BG at the position (P1) also serves as coding tumbler pin. In the case of the locking system with security reversible keys for locking installations at least two areas are defined, whereby in a first area G1 several additional security elements and a blocking code function and in the second area G2 a more simple basic coding are foreseen. With the first area G1, an unequivocal segmentation into independent market areas (M1, M2, M3) is defined and with this a world-wide unique locking system with enhanced security and applicability is created.
Patent NZ-518223-A (NZ)
Title: Whey protein emulsion
Inventor: PERNELL CHRIS
IPC: A23C19/072
Filed: 2001-04-24
Abstract: The application discloses a method for producing cheese. The said method comprising: a) Subjecting the mixture of i) cream and ii) a whey protein preparation to a homogenization process, wherein said whey protein preparation comprises hydrolyzed whey proteins b) Mixing said homogenized mixture for said a) of the milk to provide a cheese milk and c) Producing cheese from said cheese milk, wherein said cheese has improved meltability compared to cheese made using an unhydrolysed whey protein preparation.
Patent NZ-518319-A (NZ)
Title: Nucleic acid molecules encoding serum amyloid A isoforms from mammalian colostrum used to treat and prevent enteric infections
Inventor: MCDONALD THOMAS L
IPC: C12N5/10
Filed: 2000-10-20
Abstract: A Serum Amyloid A protein (SAA), isolated and purified from mammalian colostrum, is disclosed. The SAA has been isolated from colostrum of several mammalian species, including horse, cow and sheep. Nucleic acid molecules encoding the colostrum SAA, and antibodies immunologically specific for the colostrum SAA, are also disclosed. The colostrum associated SAA, particularly the highly conserved region, (TFLK), also has an ability to stimulate mucin 3 (MUC3) production. Thus colostrum associated SAA may be used to treat and prevent enteric infections or other mucin inhibited disease states, such as traveller's diarrhoea, infant diarrhoea, narcotising enterocolitis, urinary infections, and veterinary medicine for prevention of diarrhoea in herd animals. Also described are pharmaceutical compositions comprising a pharmaceutically effective amount of colostrum associated SAA peptide and a carrier to treat these and other diseases with similar pathology. Finally, other epithelial cell linings of mucosal surfaces such asnasopharynx, bladder etc., which produce mucins may also be treated with the pharmaceutical compositions described to stimulate mucin production to prevent or treat infections associated therewith.
Patent NZ-519407-A (NZ)
Title: Dressing with directional fibres to wick exudates away from wounds to an absorbant fabric
Inventor: ANCELL WILLIAM
IPC: D06C23/02
Filed: 2000-11-09
Abstract: A  dressing and a method of manufacturing a  dressing; the  dressing  comprising an absorbent support  fabric  (2), and  a polyester fiber sheet (1) attached to one surface  of the  absorbent support fabric to provide a wicking path such that  exudates  contacting an outer  surface  of  the  fiber sheet  are wicked to the absorbent support fabric. The outer surface  of  the  polyester fiber sheet is  heat-treated  to hinder  individual fibers from extending out of the  surface and  thereby  produce a glazed effect. This  glazed  surface inhibits the dressing from sticking to a wound, and  impedes exudate  transported within the dressing from  returning  to the dressing surface.
Patent NZ-522935-A (NZ)
Title: Interface device between computer and lift control for lift or elevator modernisation
Inventor: FRIEDLI PAUL
IPC: B66B7/00
Filed: 2002-12-03
Abstract: A lift installation that includes a lift 11 and a lift control 14 for controlling the lift in accordance with at least one call report is modernized by the inclusion of an interface device 36, 36' that receives a destination signal 37 delivered from a computer unit 30 of the lift installation, and that converts the destination signal into at least one call report 16, 18 so that the device controls the lift control by the call report.
Patent NZ-525707-A (NZ)
Title: Process for the production of 16,17-[(cyclohexylmethylene) bis(oxy)]-11,21-dihydroxy-pregna-1,4-diene-3,20-dione or its 21-isobutyrate by transketalisation
Inventor: SCHMIDT BEATE
IPC: C07B61/00
Filed: 2001-11-06
Abstract: Disclosed is a process for the preparation of a compound of formula 1, in which R is hydrogen or isobutyryl, the process comprising: reacting a compound of formula 2, in which R is hydrogen or isobutyryl, R1 is alkyl, and R2 is alkyl, with cyclohexanealdehyde.
Patent NZ-528364-A (NZ)
Title: CRF receptor antagonists
Inventor: DI FABIO ROMANO
IPC: A61P25/22
Filed: 2002-04-30
Abstract: Tricyclic pyrimidines compounds of formula (I) including stereoisomers, prodrugs and pharmaceutically acceptable salts or solvates thereof are disclosed, wherein R is aryl or heteroaryl, wherein each of the above groups R may be substituted by 1 to 4 substituents independently selected from the group consisting of: halogen, C1-C6 alkyl, C1-C6 alkoxy, halo C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, halo C1-C6 alkoxy, C1-C6 mono or dialkylamino, nitro, cyano and a group R4; R1 is hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, halo C1-C6 alkyl, halo C1-C6 alkoxy, NH2, halogen or cyano; R2 is hydrogen or C(H)n(R5)q(CH2)pZR6; R3 is hydrogen, C2-C6 alkenyl, C2-C6 alkynyl or [CH(R5)(CH2)p]mZR6; R4 is C3-C7 cycloalkyl, which may contain one or more double bonds; aryl; or a 5-6 membered heterocycle; wherein each of the above groups R4 may be substituted by one or more groups selected from: halogen, C1-C6 alkyl, C1-C6 alkoxy, halo C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, halo C1-C6 alkoxy, C1-C6 mono or dialkylamino, nitro, and cyano; R5 is hydrogen, C2-C6 alkenyl, C2-C6 alkynyl or (CH2)pZR6; R6 is C1-C6 alkyl, which may be substituted by one or more groups selected from halogen, halo C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, halo C1-C6 alkoxy, C1-C6 alkoxy, C1-C6 mono or dialkylamino, nitro, cyano and a group R4; Y is carbon or nitrogen; m and n are independently 0 or 1; p is 0 or an integer from 1 to 4; q is 1 or 2; Z is a bond, O, NH or S. Processes for the preparation of compounds of formula (I), pharmaceutical compositions containing them and to their use in the treatment of central nervous system disorders where corticotropin-releasing factor (CRF) receptors are involver.
Patent NZ-530515-A (NZ)
Title: Apparatus for use in exercising
Inventor: WILCOCKS RODNEY EDWARD
IPC: A63B21/055
Filed: 2002-07-05
Abstract: Apparatus (10) for use in exercising, including means for engaging (12) the foot (22) of one leg (30) of a user (16) of the apparatus (10), wherein the means for engaging (12) is adapted to retard movement of the foot (22) as the foot moves from a first position towards a second position. The means for engaging is in the form of an endless loop that is at least partially elastically deformable, the loop being positionable beneath the foot and above the knee. A handle is coupled to a section of the endless loop positionable above the knee. The use of a means for engaging the foot of one leg of a person, wherein means for engaging is adapted to retard movement of the foot as the foot moves from a first position towards a second position, the means for engaging being in the form of an endless loop that is at least partially elastically deformable, the loop being positionable beneath the foot and above the knee, in the manufacture of an apparatus for the prophylaxis of deep vein thrombosis is also claimed. Addition number 535292
Patent NZ-530739-A (NZ)
Title: Securing strap arrangement and tensioner therefor
Inventor: SHAW STEPHEN JAMES
Filed: 2001-08-01
Abstract: A securing strap arrangement, typically for securing luggage or other items, has a resiliently extensible length portion (10), and a substantially non-resiliently extensible length portion (5) including an arrangement for varying the effective length of the non-resiliently extensible length portion. The arrangement includes a tensioner grip (9) to stretch the extensible length portion (10), and a tensioner grip locator (11) arranged such that the tensioner grip is releasably engageable with the tensioner grip locator in one of a plurality of location positions, the location positions being spaced in the longitudinal direction of the strap arrangement.
Patent NZ-533318-A (NZ)
Title: Animal bit
Inventor: BLADEN ROY VICTOR
Filed: 2004-06-03
Abstract: An animal bit is provided for administration of animal remedies. The bit includes a straight portion which is held transversely across the animals mouth and which includes an aperture. The aperture is adapted to accommodate and guide an application device such as a syringe so that the remedy is directed onto a central rear portion of the animals tongue.